Search for: "Myriad Genetic Laboratories, Inc."
Results 41 - 60
of 93
Sorted by Relevance
|
Sort by Date
26 Oct 2021, 6:53 am
Myriad Genetics, a decision that has since come under intense pressure by moneyed interests. [read post]
20 May 2010, 2:27 pm
This innovation breathes new importance into the Bilski case and into the Federal Circuit ultimately reversing Judge Sweet’s decision invalidating the Myriad Genetics patents, which we all know they will do. [read post]
21 May 2012, 8:25 am
Prometheus Laboratories, Inc., 566 U.S. ___ (2012). [read post]
17 Apr 2013, 11:50 am
A writ of certiorari was granted by the Supreme Court, which vacated the Court of Appeal's decision, remanding the case for re-evaluation, in light of Mayo Collaborative Services v Prometheus Laboratories Inc. [read post]
19 Dec 2011, 1:38 pm
Prometheus Laboratories, Inc., (reported in our December 7th post) the American Civil Liberties Union Foundation (“ACLU”) and the Public Patent Foundation petitioned the U.S. [read post]
8 Apr 2014, 11:38 am
Myriad Genetics, Inc., 569 U.S. __, 133 S. [read post]
20 Jul 2012, 12:50 pm
Prometheus Laboratories Inc. [read post]
10 Apr 2012, 10:57 am
Myriad Genetics, Inc., the Supreme Court granted certiorari, vacated the Federal Circuit decision and remanded for further consideration of patentability of Myriad's claims to isolated DNA strands based upon the outcome of Mayo v. [read post]
23 Nov 2022, 6:14 am
Myriad Genetics, Inc., 133 S.Ct. 2107 (2013) and Mayo Collaborative Services v. [read post]
14 Apr 2018, 11:46 am
Myriad Genetics,Inc., 569 U.S. 576 (2013) and Mayo Collaborative Servicesv. [read post]
10 Jun 2012, 9:40 pm
Myriad Genetics et al. [read post]
3 Feb 2012, 8:48 am
Myriad Genetics Star Northwest v. [read post]
15 Dec 2010, 7:36 am
Both of those cases (Classen Immunotherapies, Inc. v. [read post]
1 Apr 2012, 10:00 pm
Prometheus Laboratories, Inc., and addressed the question as to when medical diagnostic methods fulfill the patentable subject matter requirement of Section 101 in the Patent Code. [read post]
1 Apr 2012, 10:00 pm
Prometheus Laboratories, Inc., and addressed the question as to when medical diagnostic methods fulfill the patentable subject matter requirement of Section 101 in the Patent Code. [read post]
8 Apr 2014, 8:02 am
Prometheus Laboratories, Inc., Ass'n for Molecular Pathology v. [read post]
7 Aug 2019, 10:00 pm
Myriad Genetics, Inc. 569 U.S. 576, 591 (2013). [read post]
13 Aug 2017, 12:54 am
This suggests to me that the Patent Office is continuing to grapple with the principles of patent-eligibility set out in Research Affiliates, RPL Central, and D’Arcy v Myriad Genetics Inc [2015] HCA 35, and that applicants therefore still cannot expect predictable or consistent outcomes as examiners endeavour to apply these principles on a case-by-case basis. [read post]
Examining Eligibility: USPTO Guidelines on Products of Nature, Laws of Nature, and Natural Phenomena
4 Mar 2014, 2:01 pm
Myriad Genetics, Inc., 569 U.S. _, 133 S. [read post]
30 Oct 2010, 6:01 pm
A federal judge in New York City said no last March, but a genetic research company, Myriad Genetics, Inc., has appealed. [read post]
